Skip to main content
. 2019 Sep 19;9:12986. doi: 10.1038/s41598-019-49364-x

Figure 1.

Figure 1

Repeated LV injection of liraglutide attenuates development of hypertension in SHR. Effect of repeated LV injection of 0.9 µg liraglutide or saline once a day for 15 days on systolic blood pressure (A) and heart rate (B) in SHR (n = 5) and WKY rats (n = 5–6), and systolic blood pressure (C) in liraglutide-injected SHR (n = 5) and saline-injected SHR pair-fed to liraglutide-injected group (n = 5). Data are shown as mean ± SE. *P < 0.05 between liraglutide and saline groups by repeated measures two-way ANOVA followed by Turkey’s post hoc test. Figure A (SHR): P value for time, group and time x group interaction are p < 0.0001, p = 0.0409 and p = 0.0301, respectively. Figure C: P value for time, group and time x group interaction are p < 0.0001, p = 0.7918 and p = 0.0045, respectively.